Tesamorelin Tracker App
Track Visceral Fat Reduction Peptide
Track your Tesamorelin (Egrifta) injections. This FDA-approved peptide specifically targets visceral belly fat by stimulating natural growth hormone release. Log your daily injections and track your abdominal measurements.
What is Tesamorelin?
Tesamorelin is a stabilized synthetic GHRH analog approved by the FDA (as Egrifta) for reducing excess abdominal fat in HIV patients. It is widely used off-label for general visceral fat reduction and body composition improvement.
Unlike other GH peptides, Tesamorelin is specifically noted for its ability to target visceral adipose tissue (deep belly fat). Typical protocols involve daily subcutaneous injections of 1-2mg.
FAQ
How long until I see results with Tesamorelin?
Clinical studies showed significant visceral fat reduction after 26 weeks of daily use. Consistency is key, and Shotlee helps you stay on track.
Can I combine Tesamorelin with Ipamorelin?
Yes! Many users stack Tesamorelin (a GHRH) with Ipamorelin (a GHRP) for synergistic growth hormone release. Shotlee allows tracking multiple peptides.